Search Results - "ZHENGSHENG YAO"

Refine Results
  1. 1

    Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer by Zhang, Meili, Yao, Zhengsheng, Dubois, Sigrid, Ju, Wei, Müller, Jürgen R, Waldmann, Thomas A

    “…IL-15 has potential as an immunotherapeutic agent for cancer treatment because it is a critical factor for the proliferation and activation of natural killer…”
    Get full text
    Journal Article
  2. 2

    Combined-modality radioimmunotherapy : synergistic effect of paclitaxel and additive effect of bevacizumab by Jang, Beom-Su, Lee, Sang-Myung, Kim, Hyung Sub, Shin, In Soo, Razjouyan, Faezeh, Wang, Shutao, Yao, Zhengsheng, Pastan, Ira, Dreher, Matthew R, Paik, Chang H

    Published in Nuclear medicine and biology (01-05-2012)
    “…Abstract Introduction This study was undertaken to investigate the effect of paclitaxel and bevacizumab on the therapeutic efficacy of90 Y-labeled B3…”
    Get full text
    Journal Article
  3. 3

    Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the α-emitting radionuclide, bismuth 213 by Zhang, Meili, Yao, Zhengsheng, Garmestani, Kayhan, Axworthy, Donald B., Zhang, Zhuo, Mallett, Robert W., Theodore, Louis J., Goldman, Carolyn K., Brechbiel, Martin W., Carrasquillo, Jorge A., Waldmann, Thomas A.

    Published in Blood (01-07-2002)
    “…We used a pretargeting technique to treat a nonobese diabetic/severe combined immunodeficient murine model of human adult T-cell leukemia with an anti-Tac…”
    Get full text
    Journal Article
  4. 4

    Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors by Zhang, Meili, Yao, Zhengsheng, Zhang, Zhuo, Garmestani, Kayhan, Goldman, Carolyn K., Ravetch, Jeffrey V., Janik, John, Brechbiel, Martin W., Waldmann, Thomas A.

    Published in Blood (15-07-2006)
    “…CD30 is a member of the tumor necrosis factor receptor family. Overexpression of CD30 on some neoplasms versus its limited expression on normal tissues makes…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Effect of albumin fusion on the biodistribution of interleukin-2 by ZHENGSHENG YAO, WEILI DAI, PERRY, James, BRECHBIEL, Martin W, SUNG, Cynthia

    Published in Cancer Immunology, Immunotherapy (01-05-2004)
    “…We investigated and compared the biodistribution of Albuleukin, a human serum albumin (HSA)-interleukin-2 (IL-2) fusion protein, with those of IL-2 and HSA…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Effect of Molecular Size of Pegylated Peptide on the Pharmacokinetics and Tumor Targeting in Lymphoma-Bearing Mice by DeNardo, Sally J, Yao, Zhengsheng, Lam, Kit S, Song, Aimin, Burke, Patricia A, Mirick, Gary R, Lamborn, Kathleen R, O'Donnell, Robert T, DeNardo, Gerald L

    Published in Clinical cancer research (01-09-2003)
    “…Purpose: Rapid blood and body clearances have hampered effective tumor targeting by small molecules. We used branched poly(ethylene glycol) (pegylated)…”
    Get full text
    Journal Article
  9. 9

    Comparative Cellular Catabolism and Retention of Astatine-, Bismuth-, and Lead-Radiolabeled Internalizing Monoclonal Antibody by Yao, Zhengsheng, Garmestani, Kayhan, Wong, Karen J, Park, Luke S, Dadachova, Ekaterina, Yordanov, Alexander, Waldmann, Thomas A, Eckelman, William C, Paik, Chang H, Carrasquillo, Jorge A

    Published in The Journal of nuclear medicine (1978) (01-10-2001)
    “…Monoclonal antibodies (mAbs) labeled with alpha-emitting radionuclides such as (211)At, (212)Bi, (213)Bi, and (212)Pb (which decays by beta-emission to its…”
    Get full text
    Journal Article
  10. 10
  11. 11

    IL-15 enhanced antibody-dependent cellular cytotoxicity mediated by NK cells and macrophages by Zhang, Meili, Wen, Bernard, Anton, Olga M., Yao, Zhengsheng, Dubois, Sigrid, Ju, Wei, Sato, Noriko, DiLillo, David J., Bamford, Richard N., Ravetch, Jeffrey V., Waldmann, Thomas A.

    “…The goal of cancer immunotherapy is to stimulate the host immune system to attack malignant cells. Antibody-dependent cellular cytotoxicity (ADCC) is a pivotal…”
    Get full text
    Journal Article
  12. 12

    The Relationship of Glycosylation and Isoelectric Point with Tumor Accumulation of Avidin by Yao, Zhengsheng, Zhang, Meili, Sakahara, Harumi, Nakamoto, Yuji, Higashi, Tatsuya, Zhao, Songji, Sato, Noriko, Arano, Yasushi, Konishi, Junji

    Published in The Journal of nuclear medicine (1978) (01-03-1999)
    “…Radiolabeled avidin markedly accumulated in intraperitoneal tumors and was cleared rapidly from circulation when given intraperitoneally. This study…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Intratumoral Distribution of Radiolabeled Antibody and Radioimmunotherapy in Experimental Liver Metastases Model of Nude Mouse by Sato, Noriko, Saga, Tsuneo, Sakahara, Harumi, Yao, Zhengsheng, Nakamoto, Yuji, Zhang, Meili, Kuroki, Masahide, Matsuoka, Yuji, Iida, Yasuhiko, Konishi, Junji

    Published in The Journal of nuclear medicine (1978) (01-04-1999)
    “…The biodistribution and intratumoral distribution of radiolabeled anticarcinoembryonic antigen (CEA) monoclonal antibody in experimental liver metastases and…”
    Get full text
    Journal Article
  15. 15

    Tumor targeting properties of two monoclonal antibodies directed against two different antigens, shed and non-shed, expressed on the same tumor by Lee, Jae-Ho, Kim, Heejung, Yao, Zhengsheng, Kim, Insook, Szajek, Lawrence, Grasso, Luigi, Pastan, Ira, Paik, Chang

    Published in The Journal of nuclear medicine (1978) (01-05-2017)
    “…Objectives: To investigate key parameters to improve the tumor delivery and penetration. We performed biodistribution (BD), PET imaging and autoradiography…”
    Get full text
    Journal Article
  16. 16

    Improved renal clearance and tumor targeting of 99mTc-labeled anti-Tac monoclonal antibody Fab by chemical modifications by KIM, Meyoung-Kon, JEONG, Hyeh-Jean, KAO, Chih-Hao K, ZHENGSHENG YAO, PAIK, David S, JAE EUN PIE, KOBAYASHI, Hisataka, WALDMANN, Thomas A, CARRASQUILLO, Jorge A, PAIK, Chang H

    Published in Nuclear medicine and biology (01-02-2002)
    “…This study was undertaken to improve the renal clearance and tumor targeting properties of 99mTc-labeled humanized anti-Tac (HuTac) monoclonal antibody Fab…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Tumor-Shed Antigen Affects Antibody Tumor Targeting: Comparison of Two 89 Zr-Labeled Antibodies Directed against Shed or Nonshed Antigens by Lee, Jae-Ho, Kim, Heejung, Yao, Zhengsheng, Szajek, Lawrence P., Grasso, Luigi, Kim, Insook, Paik, Chang H.

    “…We investigated the effect of shed antigen mesothelin on the tumor uptake of amatuximab, a therapeutic anti-mesothelin mAb clinically tested in mesothelioma…”
    Get full text
    Journal Article
  19. 19

    Tumor and organ uptake of (64)Cu-labeled MORAb-009 (amatuximab), an anti-mesothelin antibody, by PET imaging and biodistribution studies by Lee, Jae-Ho, Kim, Heejung, Yao, Zhengsheng, Lee, Sung-Jin, Szajek, Lawrence P, Grasso, Luigi, Pastan, Ira, Paik, Chang H

    Published in Nuclear medicine and biology (01-11-2015)
    “…To investigate the effect of the injection dose of MORAb-009 (amatuximab, an anti-mesothelin monoclonal antibody), the tumor size and the level of shed…”
    Get full text
    Journal Article
  20. 20

    Anti‐murine Antibody Response to Mouse Monoclonal Antibodies in Cancer Patients by Sakahara, Harumi, Saga, Tsuneo, Onodera, Hisashi, Yao, Zhengsheng, Nakamoto, Yuji, Zhang, Meili, Sato, Noriko, Nakada, Hiroshi, Yamashina, Ikuo, Endo, Keigo, Konishi, Junji

    Published in Japanese Journal of Cancer Research (01-09-1997)
    “…Although development of human anti‐murine inununoglobulin antibody (HAMA) is often seen in patients receiving murine antibodies, the variety of methods used…”
    Get full text
    Journal Article